Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]

RIGL Rating Summary

RIGL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RIGL
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $7.25 (+220.8%) * Over Last 12-Mos
Rating Score: 4.5 / 10   Percentile Rank: 48%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/13/2016 H.C. Wainwright New Coverage Buy
(N/A)
6.00
(N/A)
2.25 2.26 0.44% Details
6/13/2016 Piper Jaffray New Coverage Overweight
(N/A)
10.00
(N/A)
2.39 2.26 -5.44% Details